These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9713327)

  • 1. Factors regulating the rat insulin-like growth factor-binding protein-1 response to octreotide.
    Lewitt MS; Cameron-Smith D; Clarke NM; Saunders H; Phuyal JL
    J Endocrinol; 1998 Jul; 158(1):61-8. PubMed ID: 9713327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Octreotide stimulates insulin-like growth factor-binding protein-1: a potential pituitary-independent mechanism for drug action.
    Ezzat S; Ren SG; Braunstein GD; Melmed S
    J Clin Endocrinol Metab; 1992 Dec; 75(6):1459-63. PubMed ID: 1281485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of hepatic insulin-like growth factor-binding protein-1 and -3 gene expression by octreotide in rats.
    Flyvbjerg A; Schuller AG; van Neck JW; Groffen C; Orskov H; Drop SL
    J Endocrinol; 1995 Dec; 147(3):545-51. PubMed ID: 8543925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Octreotide prevents the early increase in renal insulin-like growth factor binding protein 1 in streptozotocin diabetic rats.
    Raz I; Rubinger D; Popovtzer M; Grønbaek H; Weiss O; Flyvbjerg A
    Diabetes; 1998 Jun; 47(6):924-30. PubMed ID: 9604870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Octreotide stimulates insulin-like growth factor binding protein-1 (IGFBP-1) levels in acromegaly.
    Ezzat S; Ren SG; Braunstein GD; Melmed S
    J Clin Endocrinol Metab; 1991 Aug; 73(2):441-3. PubMed ID: 1713220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of chronic treatment with octreotide nasal powder on serum levels of growth hormone, insulin-like growth factor I, insulin-like growth factor binding proteins 1 and 3 in acromegalic patients.
    Invitti C; Fatti L; Camboni MG; Porcu L; Danesi L; Delitala G; Cavagnini F
    J Endocrinol Invest; 1996 Sep; 19(8):548-55. PubMed ID: 8905479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body composition and circulating levels of insulin, insulin-like growth factor-binding protein-1 and growth hormone (GH)-binding protein affect the pharmacokinetics of GH in adults independently of age.
    Hansen TK; Jørgensen JO; Christiansen JS
    J Clin Endocrinol Metab; 2002 May; 87(5):2185-93. PubMed ID: 11994362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of endogenous insulin secretion regulates the rapid rise of insulin-like growth factor binding protein (IGFBP)-1 levels following acute hypoglycaemia.
    Cotterill AM; Holly JM; Amiel S; Wass JA
    Clin Endocrinol (Oxf); 1993 Jun; 38(6):633-9. PubMed ID: 7687525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin analog induces insulin-like growth factor binding protein-1 (IGFBP-1) expression in human hepatoma cells.
    Ren SG; Ezzat S; Melmed S; Braunstein GD
    Endocrinology; 1992 Nov; 131(5):2479-81. PubMed ID: 1385103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of insulin-like growth factor binding protein-1 during the 24-hour metabolic clock and in response to hypoinsulinemia induced by fasting and Sandostatin in normal women.
    Holden JP; Butzow TL; Laughlin GA; Ho M; Morales AJ; Yen SC
    J Soc Gynecol Investig; 1995; 2(1):38-44. PubMed ID: 9420847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered regulation of insulin-like growth factor binding protein-1 in patients with polycystic ovary syndrome.
    Carmina E; Stanczyk FZ; Morris RS; Lee PD; Savjani G; Lobo RA
    J Soc Gynecol Investig; 1995; 2(6):743-7. PubMed ID: 9420884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of epidermal growth factor on circulating levels of free and total IGF-I and IGF-binding proteins in adult rats.
    Frystyk J; Vinter-Jensen L; Skjaerbaek C; Flyvbjerg A
    Growth Regul; 1996 Mar; 6(1):48-54. PubMed ID: 8717450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response study and long term effect of the somatostatin analog octreotide in patients with therapy-resistant acromegaly.
    Quabbe HJ; Plöckinger U
    J Clin Endocrinol Metab; 1989 May; 68(5):873-81. PubMed ID: 2565912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Octreotide: a long-acting inhibitor of endogenous hormone secretion for human metabolic investigations.
    Krentz AJ; Boyle PJ; Macdonald LM; Schade DS
    Metabolism; 1994 Jan; 43(1):24-31. PubMed ID: 8289671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy.
    Barreca A; Bozzola M; Cesarone A; Steenbergh PH; Holthuizen PE; Severi F; Giordano G; Minuto F
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3534-41. PubMed ID: 9768660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The somatostatin analogue SOM230, compared with octreotide, induces differential effects in several metabolic pathways in acromegalic patients.
    van der Hoek J; van der Lelij AJ; Feelders RA; de Herder WW; Uitterlinden P; Poon KW; Boerlin V; Lewis I; Krahnke T; Hofland LJ; Lamberts SW
    Clin Endocrinol (Oxf); 2005 Aug; 63(2):176-84. PubMed ID: 16060911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of repeated doses and continuous infusions of the growth hormone-releasing peptide hexarelin in conscious male rats.
    Conley LK; Gaillard RC; Giustina A; Brogan RS; Wehrenberg WB
    J Endocrinol; 1998 Sep; 158(3):367-75. PubMed ID: 9846166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of growth hormone effect on insulin-associated suppression of insulinlike growth factor binding protein 1 in humans.
    Conover CA; Butler PC; Wang M; Rizza RA; Lee PD
    Diabetes; 1990 Oct; 39(10):1251-6. PubMed ID: 1698676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-binding protein-1 modulates blood glucose levels.
    Lewitt MS; Denyer GS; Cooney GJ; Baxter RC
    Endocrinology; 1991 Oct; 129(4):2254-6. PubMed ID: 1717244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The somatostatin analogue, octreotide, modifies both steroidogenesis and IGFBP-1 secretion in human luteinizing granulosa cells.
    Mimuro T; Smith H; Iwashita M; Illingworth PJ
    Hum Reprod; 1998 Jan; 13(1):150-3. PubMed ID: 9512248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.